# Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions

> **NCT00829530** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ramipril 10 mg capsule
- **DRUG:** Altace® 10 mg capsule

## Key facts

- **NCT ID:** NCT00829530
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00829530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00829530, "Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00829530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*